Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2

Vaccine

Volumn 14, Issue 6, 1996, Pages 521-525

  Corbeil, Serge ^a   Seguin, Cecile ^a   Trudel, Michel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Complement; mAb; RSV

Indexed keywords

COBROTOXIN; COMPLEMENT; GAMMA INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 18A2B2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

EID: 0029946177     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00222-M     Document Type: Article

References (35)

1. McIntosh, K. and Chanock, R.M. Respiratory syncytial viruses. In: Field's Virology, 2nd edn. (Eds Fields, B.N. and Knipe, D.M.). Raven Press, New York, 1990, pp. 1045-1072
2. Anderson, L.J. and Heilman, C.A. Protective and disease-enhancing immune response to respiratory syncytial virus. J. Infect. Dis. 1995, 171, 1-7
3. Anderson, L.J., Bingham, P. and Hierholzer, J.C. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J. Virol. 1988, 62, 4232-4238
4. Taylor, G., Stott, E.J., Fernie, B.F. et al. Monoclonal antibodies that protect against respiratoy syncytial virus infection in mice. Immunology 1984, 52, 137-142
5. Trudel, M., Nadon, F., Céguin, C., Ghoubril, S., Payment, P. and Trépanier, P. Immunovirological studies on human respiratory syncytial virus strutural proteins. Can. J. Microbiol. 1986, 32, 15-21
6. Trudel, M., Nadon, F., Céguin, C., Dionne, G. and Lacroix, M. Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus. J. Gen. Virol. 1987, 68, 2273-2280
7. Trudel, M., Nadon, F., Séguin, C., Payment, P. and Talbot, P.J. Respiratory syncytial virus fusion glycoprotein: further characterization of a major epitope involved in virus neutralization. Can. J. Microbiol. 1987, 33, 933-938
8. Norrby, E., Mufson, M.A., Alexander, H., Houghton, R.A. and Lerner, R.A. Site directed serology with synthetic peptide representing the large glycoprotein G of respiratory syncytial virus. Proc. Natl Acad. Sci. USA 1987, 84, 6572-6576
9. Akerlind-Stopner, B., Utter, G., Mufson, M.A., Orvell, C., Lerner, L.A. and Norrby, E. A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulphide-binded loop. J. Virol. 1990, 64, 5143-5148
10. Trudel, M., Nadon, F., Céguin, C. and Binz, H. Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein. Virology 1991, 185, 749-757
11. Fleming, J.O., Shubin, R.A., Sussman, M.A., Casteel, N. and Stohlman, S.A. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 1989, 168, 162-167
12. Koolen, M.J.M., Borst, M.A.J., Horzinek, M.C. and Spaan, W.J.M. Immunogenic peptide comprizing a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J. Virol. 1990, 64, 6270-6273
13. Almeida, J.D. and Waterson, A.P. The morphology of virus-antibody interaction. Adv. Virus Res. 1969, 15, 307-338
14. Stolar, V. Immune lysis of Sinbis virus. Virology 1975, 66, 620-624
15. Oldstone, M.B.A., Cooper, N.R. and Larson, D.L. Formation and biologic role of polyoma virus-antibody complexes. J. Exp. Med. 1974, 140, 549-564
16. Hirsch, R.L. The complement system: its importance in the host response to viral infection. Microbiol. Rev. 1982, 46, 71-85
17. Prince, G.A., Hemming, V.G., Horswood, R.L., Baron, P.A., Murphy, B.R. and Chanock, R.M. Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats. J. Virol. 1990, 64, 3091-3092
18. Manil, L., Motte, P., Perras, P., Troalen, F., Bohuon, C. and Bellet, D. Evaluation of protocols for purification of mouse monoclonal antibodies. J. Immunol. 1986, 90, 25
19. Laemmli, U.K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680
20. Cochrane, C.G., Muller-Eberhard, H.J. and Aikin, B. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J. Immunol. 1970, 105, 55-69
21. Oldstone, M.B.A., Sissons, J.G.P. and Fujinami, R.S. Action of antibody and complement in regulating virus infection. In: Progress in Immunology IV (Eds Fougereau, M. and Dausset, J.). Academic Press, London, 1980, Chap. 33, pp. 599-620
22. Lamarre, A. and Talbot, P.J. Protection from lethal coronavirus infection by immunoglobulin fragments. J. Immunol. 1995, 154, 3975-3984
23. Bosma, G.C., Custer, R.P. and Bosma, M.J. A severe combined immunodeficiency mutation in the mouse. Nature 1983, 301, 527-530
24. Shultz, L.D. and Sidman, C.L. Genetically determined murine models of immunodeficiency. A. Rev. Immunol. 1987, 5, 367-403
25. Roder, J.C. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J. Immunol. 1979, 123, 2168-2173
26. Roder, J.C., Lohmann-Matthes, M.L., Domzig, W. and Wigzell, H. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J. Immunol. 1979, 123, 2174-2181
27. Roder, J.C. and Duwe, A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature 1979, 278, 451-453
28. Welsh, R.M. Jr and Kiessling, R.W. Natural killer cell response to lymphocytic choriomeningitis virus in beige mice. Scand. J. Immunol. 1980, 11, 363-367
29. Shellam, G.R., Allan, J.E., Papadimitriou, J.M. and Bancroft, G.J. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl Acad. Sci. USA 1981, 78, 5104-5108
30. Shin, H.S., Gewurz, H. and Snyderman, R. Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leucocytes. Proc. Soc. Exp. Biol. Med. 1969, 131, 203-207
31. Hirsch, R.L., Griffin, D.E. and Winkelstein, J.A. The effect of complement depletion on the course of Sindbis virus infection in mice. J. Immunol. 1978, 121, 1276-1278
32. Hicks, J.T., Ennis, F.A., Kim, E. and Verbonitz, M. The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J. Immunol. 1978, 121, 1437-1445
33. Stanton, G.J., Jordan, C., Hart, A., Heard, H., Langford, M.P. and Baron, S. Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. Microbial Pathogen. 1987, 3, 179-183
34. Leist, T.P., Eppler, M. and Zinkernagel, R.M. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J. Virol. 1989, 63, 2813-2819
35. Huang, S., Hendricks, W., Althage, A. et al. Immune response in mice lacking the interferon-gamma receptor. Science 1993, 259, 1742-1745